Cargando…
MDM2 promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjects
Studies have shown that single-nucleotide polymorphisms in MDM2 gene may play important roles in the development of malignant tumor. The association of del1518 polymorphism (rs3730485) in the MDM2 promoter with cancer susceptibility has been extensively studied; however, the results are contradictor...
Autores principales: | Hua, Wenfeng, Zhang, Anqi, Duan, Ping, Zhu, Jinhong, Zhao, Yuan, He, Jing, Zhang, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538693/ https://www.ncbi.nlm.nih.gov/pubmed/28794641 http://dx.doi.org/10.2147/OTT.S140424 |
Ejemplares similares
-
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
por: Gansmo, Liv B., et al.
Publicado: (2017) -
Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate
por: Gansmo, Liv B., et al.
Publicado: (2016) -
Correction to Lancet Oncol 2021; 22: 1518–29
Publicado: (2022) -
A case‐control study on the SNP309T → G and 40‐bp Del1518 of the MDM2 gene and a systematic review for MDM2 polymorphisms in the patients with breast cancer
por: Jalilvand, Amin, et al.
Publicado: (2020) -
MDM4 rs4245739 A > C polymorphism correlates with reduced overall cancer risk in a meta-analysis of 69477 subjects
por: Xu, Chaoyi, et al.
Publicado: (2016)